Clinical Trial Update: Atripla to Raltegravir Switch Study for CNS Toxicity [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing continuing Atripla versus switching to raltegravir to address CNS toxicity in HIV infection; results completed with posting in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate)
• Raltegravir (raltegravir)

Snippet

Sponsor: St Stephens Aids Trust | Conditions: HIV Infection | Phase 3 | Status: COMPLETED | Results posted: 2014-11-04